Mereo BioPharma Group PLC ADR (MREO) operating margin is -72.4%
Mereo BioPharma Group PLC ADR (MREO) operating margin is -72.4% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full MREO research page for quote, filings, and the rest of the model. This satellite exists so “Mereo BioPharma Group PLC ADR operating margin” can rank with the actual number, then send you to /stock/mreo.